NCT06841549

Brief Summary

FAPI is a new method to discover the fibrosis of cardiac myocardium in some conditions, like myocardial infarction or cardiomyopathy. This purpose of this study is to find the relationship between FAPI results and myocardial fibrosis through some clinical serum inflammatory factors level. Meanwhile, it is the first time to provide the prognostic value of FAPI in the progression of acute myocardial infarction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 3, 2021

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2025

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2025

Completed
Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

3.1 years

First QC Date

February 19, 2025

Last Update Submit

February 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • MACE

    the target vessel failure, heart failure, repeated angina, arrhythmia and all-cause death.

    the first month, the third month, the half year and the next year after acute myocardial infarction

Study Arms (2)

Echo-AMI

acute myocardial infarction followed by echo

FAPI-AMI

acute myocardial infarction followed by FAPI

Other: FAPI

Interventions

FAPIOTHER

FAPI is a new method to find the myocardial fibrosis under some conditions, like myocardial infarction or cardiac myopathy.

FAPI-AMI

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

acute myocardial infarction after successful primary percutaneous intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Xiamen University

Xiamen, Fujian, China

Location

Related Publications (1)

  • Zhang M, Quan W, Zhu T, Feng S, Huang X, Meng H, Du R, Zhu Z, Qu X, Li P, Cui Y, Shi K, Yan X, Zhang R, Li B. [68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):839-848. doi: 10.1007/s00259-022-06015-0. Epub 2022 Nov 3.

    PMID: 36326870BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

acute myocardial infarction

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2025

First Posted

February 24, 2025

Study Start

December 3, 2021

Primary Completion

January 20, 2025

Study Completion

January 25, 2025

Last Updated

February 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations